Market Research Logo

Stroke Diagnostics and Therapeutics: Global Markets

Stroke Diagnostics and Therapeutics: Global Markets

The global stroke management market was valued at $19.2 billion in 2013 and nearly $20.2 billion in 2014. This market is expected to reach nearly $28.3 billion by 2019, with a compound annual growth rate (CAGR) of 7% from 2014 to 2019.

This report provides:

An overview of the global market for stroke therapeutics and diagnostics.

Analyses of market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.

Information on the major factors driving and inhibiting growth of the global stroke diagnostics market and its products.

Identification and analysis of key market issues, trends, gaps, and opportunities within the market as well the market's sub-segments.

Comprehensive profiles of key companies and their product portfolios, and recent developments.


The report on global stroke diagnostics and management products market includes forecasts, trends and estimated sales through 2019. The report discusses in detail the market dynamics and the level of impact, key geographies and respective trends, competitive scenario that would form the base data for qualitative analysis and market estimates.

The global stroke diagnostics and management products market has been analyzed for the four main geographies of North America, Europe, Asia-Pacific and ROW. Given that the facilities available to patients vary depending on geography this is likely to have a direct impact on potential markets.

The report will discuss the various techniques used for stroke diagnostics (e.g. diagnostics imaging and magnetic resonance imaging) in detail. It will also analyze the therapeutic management of stroke (e.g. pharmacologic therapeutic modalities, stroke-related surgical and endovascular interventions). The discussions will mostly focus on what these techniques entail, expected volumes and innovations. In addition, the report investigates the various stroke management products — and how they are associated with the patient’s medical condition — and will focus on different types of products (e.g. computed tomography systems, diagnostic ultrasound systems) and related market forecasts and competitive analysis.

CHAPTER 1 INTRODUCTION
STUDY AND OBJECTIVE
STUDY BACKGROUND
SCOPE OF THE REPORT
INTENDED AUDIENCE
SOURCE OF INFORMATION AND METHODOLOGY
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL STROKE MANAGEMENT MARKET, THROUGH 2019 ($ MILLIONS)
SUMMARY FIGURE GLOBAL STROKE MANAGEMENT MARKET, 2013-2019 ($ MILLIONS)
CHAPTER 3 MARKET OVERVIEW
STROKE AND CLASSIFICATION OF STROKE
ISCHEMIC
HEMORRHAGIC
INCIDENCE AND PREVALENCE RATES
FIGURE 1 TOP 10 LEADING CAUSES OF DEATH IN THE WORLD, 2012 (MILLIONS)
TABLE 1 RISK FACTORS OF STROKE
FIGURE 2 NUMBER OF STROKES IN THE WORLD, 1990-2010 (MILLIONS)
FIGURE 3 GLOBAL INCIDENCE AND PREVALENCE OF STROKE BY REGION, 2010 (%)
TABLE 2 PREVALENCE OF STROKE IN THE U.K. BY REGION AND GENDER, 2010 (%)
TABLE 3 TOTAL NUMBER OF DEATHS FROM STROKE IN THE U.K. BY REGION, 2010 (NUMBER)
FIGURE 4 U.S. PREVALENCE OF STROKE BY AGE AND GENDER IN PERCENTAGE OF POPULATION, 2010 (%)
CLINICAL DIAGNOSIS OF STROKE
FIGURE 5 ALGORITHM FOR THE DIAGNOSIS OF ACUTE STROKE
COMPUTED TOMOGRAPHY
MAGNETIC RESONANCE IMAGING (MRI)
CAROTID ULTRASOUND
CAROTID ANGIOGRAPHY
ELECTROCARDIOGRAM
ECHOCARDIOGRAPHY
BLOOD TESTS
THERAPEUTIC INTERVENTION
CAROTID ENDARTERECTOMY
THROMBOLYSIS
TECHNOLOGY DEVELOPMENTS - ROLE OF BIOMARKERS, RISK PREDICTION AND DIAGNOSIS
DISCOVERING BIOMARKERS FOR STROKE
APPLICATIONS OF BIOMARKERS IN STROKE RESEARCH
TABLE 4 ROLE OF BIOMARKERS
High-risk Subjects
Stroke Prediction
Possible Stroke Mechanisms
Drug Response and Outcome
Surrogate Endpoints
TYPE OF BIOMARKERS IN STROKE RESEARCH
TABLE 5 BIOMARKERS FOR SPECIFIC STROKE SUBTYPES
Protein Biomarkers
Genetic biomarkers
Microvesicle
Metabolomics
LIMITATIONS OF STROKE BIOMARKERS
TABLE 6 ADVANTAGES AND DISADVANTAGES OF BIOMARKERS BY TYPE
TABLE 7 POST STROKE DISEASE MANAGEMENT - CLINICAL TRIAL
TABLE 8 CLINICAL TRIAL: A SELF-EFFICACY ENHANCING STROKE
SELF-MANAGEMENT PROGRAM FOR COMMUNITY-DWELLING
STROKE SURVIVORS (SESSMP)
TABLE 9 CLINICAL TRIAL: ADAPTIVE PHYSICAL ACTIVITY FOR CHRONIC
STROKE
TABLE 10 CLINICAL TRIAL: TAILORED APPROACHES TO STROKE HEALTH EDUCATION (TASHE)
TABLE 11 CLINICAL TRIAL: PROSPECTIVE STROKE COHORT
SUPPLY CHAIN PROCESS AND MARKET ANALYSIS
FIGURE 6 SUPPLY CHAIN ANALYSIS - STROKE DIAGNOSIS AND MANAGEMENT
FIGURE 7 FACTORS THAT INFLUENCE THE QUALITY OF THE STROKE
MANAGEMENT SUPPLY CHAIN
GEOGRAPHIC MARKET ANALYSIS: DEVELOPED VERSUS DEVELOPING
ECONOMIES
TABLE 12 HEALTHCARE EXPENDITURE COMPARISON, DEVELOPED VERSUS
DEVELOPING ECONOMIES, 2008-2012* (% OF GDP)
REGULATIONS, GOVERNMENT POLICIES, ENVIRONMENT CLEARANCES, CE
MARK/FDA APPROVALS ETC
GOVERNMENT REGULATIONS - POLICY CHANGES TO IMPROVE STROKE
CARE, U.S.
NATIONAL SUMMARY OF STATE POLICY AND REGULATION
FIGURE 8 TIMELINE FOR ENACTMENT OF PRIMARY STROKE CENTER
LEGISLATIVE OR NON-LEGISLATIVE POLICY, JULY 2010
Type of Policy
CDC FUNDING
National Heart Disease and Stroke Prevention Program
Paul Coverdell National Acute Stroke Registry
Stroke Networks
NATIONAL STROKE STRATEGY, U.K.
CE MARK/FDA APPROVALS
CASE STUDIES AND BRIEF: EMERGING DEVICE-BASED ENDOVASCULAR
THERAPIES
CEREBRAL EMBOLECTOMY/THROMBECTOMY SYSTEMS- CONCENTRIC
MEDICAL
MERCI RETRIEVER
PATIENT ENROLMENT FOR CLINICAL TRIALS - TREVO 2 IN FEBRUARY, 2011
EKOS
Aim
Methods
Results
Discussion
Conclusion
FDA APPROVAL OF BOSTON SCIENTIFIC'S STROKE FIGHTING DEVICE
EV3 - COMPARISON OF TWO STROKE DEVICES: APERIO CLOT REMOVAL AND EV3'S - SOLITAIRE AB/FR
Background
Materials and Methods
Results
Discussion
MICRUS ENDOVASCULAR - EFFECTIVENESS OF MICRUS ENDOVASCULAR
PHAROS ON A PATIENT
Clinical History
Technology Involved
Conclusion
BRAINSGATE - FDA APPROVAL ON ITS STROKE TREATMENT STUDY
BrainsGate Changed Stroke Treatment Pivotal Trial Structure in January, 2013
COAXIA
The SENTIS Stroke Trial
MARKET INTELLIGENCE
FIGURE 9 RECENT DEVELOPMENTS BY COMPANY, 2011-2014 (NUMBER OF PROJECTS)
MARKET DYNAMICS
FIGURE 10 GLOBAL POPULATION GROWTH, BY AGE GROUP, 2010-2020 (MILLIONS)
EMERGING ENDOVASCULAR THERAPEUTIC SYSTEMS
CEREBRAL EMBOLECTOMY/THROMBECTOMY SYSTEMS
INTRACRANIAL STENTING SYSTEMS
CEREBRAL PERFUSION AUGMENTATION SYSTEMS
CURRENT SCENARIO AND FUTURE TRENDS
ANALYSIS, CONCLUSIONS AND RECOMMENDATIONS
CHAPTER 4 STROKE DIAGNOSTIC AND MANAGEMENT DEVICES MARKET
STROKE DIAGNOSTICS
DIAGNOSTIC IMAGING
TABLE 13 GLOBAL STROKE DIAGNOSTIC IMAGING MARKET, THROUGH 2019 ($ MILLIONS)
TABLE 14 GLOBAL STROKE DIAGNOSTIC IMAGING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Computed Tomography
TABLE 15 GLOBAL COMPUTED TOMOGRAPHY MARKET BY SYSTEM, THROUGH 2019 ($ MILLIONS)
TABLE 16 GLOBAL COMPUTED TOMOGRAPHY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Spiral Computed Tomography
TABLE 17 GLOBAL SPIRAL COMPUTED TOMOGRAPHY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Multislice Computed Tomography
TABLE 18 GLOBAL MULTISLICE COMPUTED TOMOGRAPHY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Dual Source Multislice CT
TABLE 19 GLOBAL DUAL SOURCE MULTISLICE COMPUTED TOMOGRAPHY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Computed Tomography Angiography
TABLE 20 GLOBAL COMPUTED TOMOGRAPHY ANGIOGRAPHY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Perfusion Computed Tomography
TABLE 21 GLOBAL PERFUSION COMPUTED TOMOGRAPHY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Magnetic Resonance Imaging
TABLE 22 GLOBAL MRI MARKET BY TYPES, THROUGH 2019 ($ MILLIONS)
TABLE 23 GLOBAL MRI MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Magnetic Resonance Angiography
TABLE 24 GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Time-of-Flight Magnetic Resonance Angiography
TABLE 25 GLOBAL TOF-MRA MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Phase-Contrast Magnetic Resonance Angiography
TABLE 26 GLOBAL PC-MRA MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Contrast-Enhanced Magnetic Resonance Angiography
TABLE 27 GLOBAL CE-MRA MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Functional Magnetic Resonance Imaging
TABLE 28 GLOBAL FMRI MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Proton Magnetic Resonance Spectroscopy
TABLE 29 GLOBAL PROTON MAGNETIC RESONANCE SPECTROSCOPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Diagnostic Ultrasound
TABLE 30 GLOBAL DIAGNOSTIC ULTRASOUND MARKET, THROUGH 2019 ($ MILLIONS)
TABLE 31 GLOBAL DIAGNOSTIC ULTRASOUND MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Doppler Ultrasound
TABLE 32 GLOBAL DOPPLER ULTRASOUND MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Duplex Ultrasound
TABLE 33 GLOBAL DUPLEX ULTRASOUND MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Cerebral Angiography
TABLE 34 GLOBAL CEREBRAL ANGIOGRAPHY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Nuclear Imaging
TABLE 35 GLOBAL NUCLEAR IMAGING MARKET, THROUGH 2019 ($ MILLIONS)
TABLE 36 GLOBAL NUCLEAR IMAGING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Gamma Camera Imaging
TABLE 37 GLOBAL GAMMA CAMERA IMAGING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Positron Emission Tomography
TABLE 38 GLOBAL PET MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
CHAPTER 5 THERAPEUTIC MANAGEMENT OF STROKE
TABLE 39 GLOBAL THERAPEUTIC MANAGEMENT MARKET OF STROKE BY DRUG CATEGORY, THROUGH 2019 ($ MILLIONS)
ANTICOAGULATION THERAPY
COUMARINS (VITAMIN K ANTAGONISTS)
HEPARIN AND DERIVATIVE SUBSTANCES
OTHERS
TABLE 40 GLOBAL ANTICOAGULATION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
ANTIHYPERTENSIVE DRUG THERAPY
TABLE 41 GLOBAL ANTIHYPERTENSIVE DRUG THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
ANTIPLATELET DRUG THERAPY
TABLE 42 GLOBAL ANTIPLATELET DRUG THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
OTHER DRUG THERAPIES
TABLE 43 GLOBAL OTHER DRUG THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
KEY STROKE MANAGEMENT DRUGS (GENERIC) ANALYSIS
TABLE 44 GLOBAL STROKE MANAGEMENT DRUG MARKET, THROUGH 2019 ($ MILLIONS)
WARFARIN
TABLE 45 GLOBAL WARFARIN MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
DABIGATRAN
TABLE 46 GLOBAL DABIGATRAN MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
NADROPERIN
TABLE 47 GLOBAL NADROPERIN MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
ENAXOPERIN
TABLE 48 GLOBAL ENAXOPERIN MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
ATENOLOL
TABLE 49 GLOBAL ATENOLOL MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
METOPROLOL
TABLE 50 GLOBAL METOPROLOL MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
PINDOLOL
TABLE 51 GLOBAL PINDOLOL MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
HYDROCHLOROTHIAZIDE
TABLE 52 GLOBAL HYDROCHLOROTHIAZIDE MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
LOSARTAN
TABLE 53 GLOBAL LOSARTAN MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
ENALAPRIL
TABLE 54 GLOBAL ENALAPRIL MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
LISINOPRIL
TABLE 55 GLOBAL LISINOPRIL MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
FELODIPINE
TABLE 56 GLOBAL FELODIPINE MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
ASPIRIN
TABLE 57 GLOBAL ASPIRIN MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
DIPYRIDAMOLE
TABLE 58 GLOBAL DIPYRIDAMOLE MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
CLOPIDOGREL
TABLE 59 GLOBAL CLOPIDOGREL MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
ALTEPLASE
STROKE-RELATED SURGICAL AND ENDOVASCULAR INTERVENTIONS
TABLE 60 GLOBAL STROKE RELATED SURGICAL AND ENDOVASCULAR INTERVENTIONS MARKET, THROUGH 2019 ($ MILLIONS)
TABLE 61 GLOBAL STROKE RELATED SURGICAL AND ENDOVASCULAR INTERVENTIONS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
TREATMENT OF STROKE-PRONE CAROTID ARTERY STENOSIS
TABLE 62 GLOBAL STROKE-PRONE CAROTID ARTERY STENOSIS
MARKET, THROUGH 2019 ($ MILLIONS)
TABLE 63 GLOBAL STROKE-PRONE CAROTID ARTERY STENOSIS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Carotid Endarterectomy
TABLE 64 GLOBAL CAROTID ENDARTERECTOMY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Carotid Artery Stenting
TABLE 65 GLOBAL CAROTID ARTERY STENTING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
MANAGEMENT OF INTRACRANIAL ANEURYSMS AND ARTERIOVENOUS
MALFORMATIONS
TABLE 66 GLOBAL INTRACRANIAL ANEURYSMS AND ARTERIOVENOUS MALFORMATIONS MARKET, THROUGH 2019 ($ MILLIONS)
TABLE 67 GLOBAL INTRACRANIAL ANEURYSMS AND ARTERIOVENOUS MALFORMATIONS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Intracranial Aneurysms
TABLE 68 GLOBAL INTRACRANIAL ANEURYSMS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Arteriovenous Malformations
TABLE 69 GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Surgical Repair
TABLE 70 GLOBAL SURGICAL REPAIR MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Endovascular Embolization
TABLE 71 GLOBAL ENDOVASCULAR EMBOLIZATION MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
Stereotactic Radiotherapy
TABLE 72 GLOBAL STEREOTACTIC RADIOTHERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
CHAPTER 6 MARKET BY TYPES OF STROKES
TABLE 73 GLOBAL STROKES MARKET BY TYPE, THROUGH 2019 ($ ILLIONS)
HEMORRHAGIC
TABLE 74 GLOBAL HEMORRHAGIC STROKES MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
TABLE 75 GLOBAL HEMORRHAGIC STROKES MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
INTRACEREBRAL
TABLE 76 GLOBAL INTRACEREBRAL STROKES MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
SUBARACHNOID HEMORRHAGE
TABLE 77 GLOBAL SUBARACHNOID HEMORRHAGE STROKES MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
ISCHEMIC
TABLE 78 GLOBAL ISCHEMIC STROKES MARKET, THROUGH 2019 ($ MILLIONS)
TABLE 79 GLOBAL ISCHEMIC STROKES MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
THROMBOTIC
Unmet Medical Need
European Companies are the Major Players
TABLE 80 GLOBAL THROMBOTIC STROKES MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
EMBOLIC
TABLE 81 GLOBAL EMBOLIC STROKES MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
TRANSIENT ISCHEMIC ATTACK (TIA)
TABLE 82 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
CHAPTER 7 STROKE MANAGEMENT MARKET BY STAKEHOLDERS
SUPPLY CHAIN MEMBERS
TABLE 83 GLOBAL STROKE MANAGEMENT MARKET BY SUPPLY CHAIN MEMBERS, THROUGH 2019 ($ MILLIONS)
MANUFACTURERS
TABLE 84 GLOBAL STROKE MANAGEMENT MARKET-MANUFACTURERS, BY REGION, THROUGH 2019 ($ MILLIONS)
DISTRIBUTORS
TABLE 85 GLOBAL STROKE MANAGEMENT MARKET-DISTRIBUTORS, BY REGION, THROUGH 2019 ($ MILLIONS)
SUPPLIERS
TABLE 86 GLOBAL STROKE MANAGEMENT MARKET-SUPPLIERS, BY REGION, THROUGH 2019 ($ MILLIONS)
END-USERS
TABLE 87 GLOBAL STROKE MANAGEMENT MARKET BY END USERS, THROUGH 2019 ($ MILLIONS)
LIFE SCIENCES
TABLE 88 GLOBAL STROKE MANAGEMENT MARKET-LIFE SCIENCES, BY REGION, THROUGH 2019 ($ MILLIONS)
HOSPITALS
TABLE 89 GLOBAL STROKE MANAGEMENT MARKET-HOSPITALS, BY SIZE, THROUGH 2019 ($ MILLIONS)
TABLE 90 GLOBAL STROKE MANAGEMENT MARKET-HOSPITALS, BY REGION, THROUGH 2019 ($ MILLIONS)
DIAGNOSTIC CENTERS
TABLE 91 GLOBAL STROKE MANAGEMENT MARKET-DIAGNOSTIC CENTERS, BY REGION, THROUGH 2019 ($ MILLIONS)
PATIENTS
TABLE 92 GLOBAL STROKE MANAGEMENT MARKET-PATIENTS, BY REGION, THROUGH 2019 ($ MILLIONS)
CHAPTER 8 COMPETITIVE LANDSCAPE
FIGURE 11 RECENT DEVELOPMENT BY STRATEGIES, 2011 TO 2014 NUMBER)
CERTIFICATION
FIGURE 12 CERTIFICATION BY COMPANIES, 2011 TO 2014 (NUMBER OF CERTIFICATIONS)
TABLE 93 RECENT DEVELOPMENT – CERTIFICATION BY COMPANY, 2011 TO 2014
PRODUCT LAUNCH
FIGURE 13 PRODUCT LAUNCH BY COMPANIES, 2011 TO 2014 (NUMBER OF LAUNCHES)
TABLE 94 RECENT DEVELOPMENT-PRODUCT LAUNCH BY COMPANY, 2011 TO 2014
CHAPTER 9 GEOGRAPHIC ANALYSIS
NORTH AMERICA
TABLE 95 NORTH AMERICAN STROKE MANAGEMENT MARKET, THROUGH 2019 ($ MILLIONS)
EUROPE
TABLE 96 EUROPE GERIATRIC POPULATION STATISTICS, 1991 AND 2011 (MILLIONS)
TABLE 97 EUROPEAN STROKE MANAGEMENT MARKET, THROUGH 2019 ($ MILLIONS)
ASIA
TABLE 98 ASIA GERIATRIC POPULATION STATISTICS, 2000 AND 2025 (MILLIONS)
TABLE 99 ASIAN STROKE MANAGEMENT MARKET, THROUGH 2019 ($ MILLIONS)
REST OF THE WORLD
TABLE 100 ROW STROKE MANAGEMENT MARKET, THROUGH 2019 ($ MILLIONS)
CHAPTER 10 PATENT ANALYSIS
FIGURE 14 GLOBAL PATENTS BY COMPANY, 2008 TO 2014 (NO. OF ATENTS)
U.S. PATENT ANALYSIS
FIGURE 15 U.S. PATENTS BY TECHNOLOGY, 2008 TO 2014 (NO. OF PATENTS)
FIGURE 16 U.S. PATENTS BY COMPANY, 2008 TO 2014 (NO. OF PATENTS)
EUROPEAN PATENT ANALYSIS
FIGURE 17 EUROPEAN PATENTS BY TECHNOLOGY, 2008 TO 2014 (NO. OF PATENTS)
FIGURE 18 EUROPEAN PATENTS BY COMPANY, 2008 TO 2014 (NO. OF PATENTS)
JAPAN PATENT ANALYSIS
FIGURE 19 JAPAN PATENTS BY TECHNOLOGY, 2008 TO 2014 (NO. OF PATENTS)
FIGURE 20 JAPAN PATENTS BY COMPANY, 2008 TO 2014 (NO. OF ATENTS)
CHAPTER 11 COMPANY PROFILES
ABBOTT VASCULAR
TABLE 101 ABBOTT VASCULAR'S PRODUCT PORTFOLIO
TABLE 102 ABBOTT VASCULAR'S RECENT DEVELOPMENTS, 2011 TO AUG 2014
B BRAUN MELSUNGEN AG
TABLE 103 B BRAUN'S PRODUCT PORTFOLIO
BOSTON SCIENTIFIC CORP.
TABLE 104 BOSTON SCIENTIFIC'S PRODUCT PORTFOLIO
TABLE 105 BOSTON SCIENTIFIC’S RECENT DEVELOPMENTS, 2011 TO JUNE 2014
BRISTOL-MYERS SQUIBB
TABLE 106 BRISTOL MYERS SQUIBB PRODUCT PORTFOLIO
TABLE 107 BRISTOL MYERS SQUIBB RECENT DEVELOPMENTS - 2011 TO SEP 2014
COAXIA INC.
TABLE 108 COAXIA INC PRODUCT PORTFOLIO
CORDIS CORP.
TABLE 109 CORDIS CORP. PRODUCT PORTFOLIO
GE HEALTHCARE
TABLE 110 GE HEALTHCARE PRODUCT PORTFOLIO
TABLE 111 GE HEALTHCARE RECENT DEVELOPMENTS, 2011 TO AUG 2014
GENENTECH INC.
TABLE 112 GENENTECH’S PRODUCT PORTFOLIO
GLAXOSMITHKLINE PLC.
TABLE 113 GLAXOSMITHKLINE PLC PRODUCT PORTFOLIO
MERCK & COMPANY
TABLE 114 MERCK'S PRODUCT PORTFOLIO
TABLE 115 MERCK'S RECENT DEVELOPMENTS 2011 TO SEP 2014
MIZUHO AMERICA INC.
TABLE 116 MIZUHO AMERICA'S PRODUCT PORTFOLIO
PHILIPS HEALTHCARE
TABLE 117 PHILIPS HEALTHCARE PRODUCT PORTFOLIO
TABLE 118 PHILIPS HEALTHCARE RECENT DEVELOPMENTS, 2011 TO APRIL 2014
SIEMENS HEALTHCARE
TABLE 119 SIEMENS HEALTHCARE'S PRODUCT PORTFOLIO
CHAPTER 12 APPENDIX
UNITED STATES
TABLE 120 U.S. PATENT LIST, 2011 TO 2014
EUROPE
TABLE 121 EUROPEAN PATENT LIST, 2011 TO 2014
JAPAN
TABLE 122 JAPAN PATENT LIST, 2011 TO 2014

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report